Development and Validation of an RNA-Seq-Based Prognostic Signature in Neuroblastoma

Development and Validation of an RNA-Seq-Based Prognostic Signature in Neuroblastoma

Objective: The stratification of neuroblastoma (NBL) prognosis remains difficult. RNA-based signatures might be able to predict prognosis, but independent cross-platform validation is still rare.Methods: RNA-Seq-based profiles from NBL patients were acquired and then analyzed. The RNA-Seq prognostic...

Full description

Bibliographic Details
Main Authors: Jian-Guo Zhou, Bo Liang, Su-Han Jin, Hui-Ling Liao, Guo-Bo Du, Long Cheng, Hu Ma, Udo S. Gaipl
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-12-01
Series:Frontiers in Oncology
Subjects:
neuroblastoma
gene pairs
prognostic model
validation
overall survival
event-free survival
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.01361/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.01361/full

Similar Items